Updated Jul 16, 2026
Barchas Isaac has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.81M.
Barchas Isaac is listed in Immunome Inc.'s SEC filings as an insider as of the 2026-06-12 filing. The publicly available SEC-context data do not specify a formal title or detailed biographical background for this individual. Immunome Inc. is a biotechnology company focused on immune profiling and cancer therapies.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | IMNM | Immunome Inc. | S — Open-market sale | 16.9K | $24.20 | $409K |
| 2026-07-07 | IMNM | Immunome Inc. | S — Open-market sale | 83.1K | $24.11 | $2.00M |
| 2026-07-03 | IMNM | Immunome Inc. | S — Open-market sale | 24.3K | $23.33 | $568K |
| 2026-07-03 | IMNM | Immunome Inc. | S — Open-market sale | 75.7K | $22.35 | $1.69M |
| 2026-07-03 | IMNM | Immunome Inc. | S — Open-market sale | 101.0K | $21.12 | $2.13M |
Barchas Isaac is listed in Immunome Inc.'s SEC filings as an insider as of the 2026-06-12 filing. The publicly available SEC-context data do not specify a formal title or detailed biographical background for this individual. Immunome Inc. is a biotechnology company focused on immune profiling and cancer therapies.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($6.81M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Barchas Isaac profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.